Tiansheng Pharmaceutical Group Co Ltd

Name

Tiansheng Pharmaceutical Group Co Ltd

Legal name

天圣制药集团股份有限公司

Website

https://tszy.com.cn

Company type

Public

Founded year

2001

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Chinese patent medicine
• Pharmaceutical manufacturing
• TCM formulations
• Chemical drug production
• Medicinal herb processing

Headquarters

HQ city

Chongqing

HQ country

China

HQ region

Asia

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Manufacturing: The company manufactures TCM, chemical drugs, and healthcare products. Product categories include oral solid preparations (granules, tablets, capsules, pills), injections, and external medicines. Manufacturing operations include GMP-certified production facilities across multiple subsidiaries.
2. Pharmaceutical Distribution (Wholesale & Retail): The company operates pharmaceutical distribution covering wholesale and retail operations, with marketing network across multiple business divisions covering the entire country.
3. Medicinal Herb Planting and Processing: The company operates its own TCM medicinal herb bases to ensure product quality from the source, and processes medicinal herbs through specialized facilities.
4. Health Food and Beverage (药食同源): Expansion into health food and pharmaceutical beverage (药食同源饮料) product lines, including a beverage production line construction project, representing diversification beyond traditional pharmaceuticals.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Tiansheng Pharmaceutical Group manufactures and distributes Chinese Patent Medicines, Chemical Medicines, and Health Products from its own integrated industry chain spanning TCM herb cultivation, drug R&D across multiple institutes, GMP-certified manufacturing of oral solid dosage forms, injections and large-volume IV infusions, and a national wholesale/retail distribution network. The portfolio comprises ~300+ product varieties including 20+ proprietary IP products, 152 national medical insurance drugs and 77 national essential drugs, sold through four domestic business divisions, regional distributors and an in-house membership community health service system.

Product overview

Tiansheng Pharmaceutical Group Co Ltd is a comprehensive pharmaceutical manufacturer with three main product categories: Chinese Patent Medicines (中成药), Chemical Medicines (化学药), and Health Products (保健药品). The portfolio includes approximately 300+ pharmaceutical products including 152 national medical insurance drugs and 77 national essential drugs, with over 20 proprietary intellectual property varieties. Core products include 地贞颗粒 (gynecological), 小儿肺咳颗粒 (pediatric), 百咳静颗粒 (respiratory), 延参健胃胶囊 and 银参通络胶囊 (both national exclusive products), and 益气消渴颗粒 (diabetes). The company operates manufacturing facilities across China including oral solid dosage forms GMP-certified production capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Dizhen Granules (地贞颗粒) Dizhen Granules (地贞颗粒) is a Chinese Patent Medicine that clears deficiency heat, nourishes liver and kidney, and calms the heart and mind. It is indicated for menopausal syndrome with yin deficiency and internal heat pattern. Awarded the Jilin Province Science and Technology Progress First Award and the Chongqing High-Tech Product designation.
• Pediatric Feike Granules (小儿肺咳颗粒) Pediatric Feike Granules (小儿肺咳颗粒) is a Chinese Patent Medicine that strengthens spleen and nourishes lung, stops cough and relieves asthma. It is used for cough due to spleen-lung deficiency with phlegm-dampness obstruction in children.
• Baikejing Granules (百咳静颗粒) Baikejing Granules (百咳静颗粒) is a Chinese Patent Medicine that clears heat, transforms phlegm, stops cough and relieves asthma. It is used for cough caused by external wind-heat, common cold, and acute/chronic bronchitis.
• Yanshen Jianwei Capsules (延参健胃胶囊) Yanshen Jianwei Capsules (延参健胃胶囊) is a national exclusive Chinese Patent Medicine for digestive health, with technology level described as domestically leading and recipient of the 2023 Jilin Province Technical Invention First Prize.
• Yiqi Xiaoke Granules (益气消渴颗粒) Yiqi Xiaoke Granules (益气消渴颗粒) is a Chinese Patent Medicine that benefits qi, nourishes yin, generates fluids and stops thirst. It is indicated for Type 2 diabetes with qi-yin deficiency pattern, and won the Shanxi Province Excellent New Product Award.
• Lingjing Capsules (灵精胶囊) Lingjing Capsules (灵精胶囊) is a Chinese Patent Medicine that strengthens spleen and benefits kidney, transforms phlegm and removes stasis. It is used as auxiliary treatment for hyperlipidemia with spleen-kidney deficiency pattern.
• Baidi Ziyin Pills (百地滋阴丸) Baidi Ziyin Pills (百地滋阴丸) is a Chinese Patent Medicine that nourishes lung and kidney yin, cools blood and removes steaming. It is used for tuberculosis with lung-kidney insufficiency.
• Shenqi Yifei Pills (参芪益肺丸) Shenqi Yifei Pills (参芪益肺丸) is a Chinese Patent Medicine that strengthens spleen and benefits lung, transforms phlegm and stops cough. It is used as auxiliary treatment for tuberculosis with spleen-lung deficiency pattern.
• Runfei Huagao Ointment (润肺化核膏) Runfei Huagao (润肺化核膏) is a Chinese Patent Medicine topical ointment that nourishes blood and yin, detoxifies and removes stasis. It is used as auxiliary treatment for tuberculous pleurisy.
• Glucose Injection (葡萄糖注射液) Glucose Injection (葡萄糖注射液) is a chemical medicine infusion used for energy and fluid supplementation, hypoglycemia, hyperkalemia, tissue dehydration, and as a drug diluent.
• Yinshen Tongluo Capsules (银参通络胶囊) Yinshen Tongluo Capsules (银参通络胶囊) is a national exclusive Chinese Patent Medicine with technology and production level described as leading in China.

Quantifiable outcome

• Hubei subsidiary Phase 2 projected annual output exceeding 5 billion RMB, tax contribution over 500 million RMB
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• 区域配送商、经销商 (Regional Distributors and Dealers)coreChannel Partner/ Reseller/ DistributorThe company establishes strategic cooperative relationships with quality distributors and dealers in each region, supported by dedicated professionally trained regional sales managers who provide services, necessary assistance, and marketing promotion support.

Scale indicators6 records

Recent moves9 records

Expansion highlights4 records

Broad incumbents

• Guangzhou Pharmaceutical Holdings Limited (GPHL): One of China's largest pharmaceutical conglomerates with extensive TCM portfolio (including Wang Laoji herbal tea) and chemical drug operations. Comparable in TCM focus and national distribution, though operates at substantially larger scale and consumer brand strength.
• Beijing Tongrentang Co., Ltd. Historic Chinese TCM company with proprietary traditional formulations and national distribution. Comparable in TCM heritage and national essential drug positioning, though more premium brand-oriented and significantly larger in scale.
• Shanghai Pharmaceuticals Holding Co., Ltd. Major Chinese pharmaceutical group combining manufacturing, distribution, and retail pharmacy operations. Comparable in integrated pharmaceutical value chain from manufacturing to distribution, though operates at vastly larger scale with significant generic drug and API manufacturing.
• Yunnan Baiyao Group Co., Ltd. One of China's largest TCM companies with broad portfolio across TCM, chemical drugs, and health products. Comparable in that both are integrated TCM manufacturers with national distribution and proprietary TCM IP, though Yunnan Baiyao is significantly larger and more established in consumer healthcare brands.

Direct peers

• Henan Lingrui Pharmaceutical Co., Ltd. Chinese TCM manufacturer with comparable size and product portfolio across Chinese patent medicines and chemical drugs. Direct overlap in TCM product categories including pediatric, respiratory, and digestive therapeutic areas.
• Livzon Pharmaceutical Group Inc. Diversified Chinese pharmaceutical company with significant TCM and chemical drug operations plus biologics. Comparable in integrated pharmaceutical manufacturing, multi-dosage form production, and national distribution scale.
• China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Major Chinese TCM specialty pharmaceutical manufacturer with national distribution network and proprietary OTC and prescription TCM products. Most directly comparable to Tiansheng in terms of TCM-focused portfolio, national medical insurance drug positioning, and multi-dosage form manufacturing.
• Shijiazhuang Yiling Pharmaceutical Co., Ltd. TCM specialty pharmaceutical company focused on proprietary Chinese patent medicines with strong R&D capabilities. Comparable in TCM specialty focus, proprietary IP product strategy, and national essential drug list positioning.
• Jilin Aodong Pharmaceutical Group Co., Ltd. Chinese TCM and chemical drug manufacturer based in Jilin province with comparable product portfolio across TCM and chemical drugs. Particularly relevant given Tiansheng's recognition in Jilin (Jilin Province Technology Invention First Prize) and overlapping product categories.

Regional players

• China Grand Pharmaceutical and Healthcare Holdings Limited: Hong Kong-listed Chinese pharmaceutical company with focus on specialty pharmaceuticals including respiratory and cardiovascular categories. Comparable in specialty pharma positioning and proprietary IP products, though primarily focused on different therapeutic areas and serves international markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries7 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tiansheng Pharmaceutical Group Co Ltd